- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01787617
Aerobic Plus Resistance Training and Insulin Sensitivity in African American Men (ARTIIS)
October 29, 2024 updated by: Robert L. Newton, Jr., Pennington Biomedical Research Center
The purpose of this study is to investigate the effect of an exercise training intervention on the ability of African American males to use insulin properly.
Insulin is a hormone that helps the body use glucose.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is designed to assess the effect of exercise training on insulin resistance in African American males.
African American males have higher rates of diabetes and lower levels of fitness when compared to Caucasian males.
A project such as this is necessary because there is evidence to show that exercise training can reduce the risk of developing diabetes, though no studies have been conducted in African American males.
In addition, ARTIIS will test the effect adhering to the 2008 Physical Activity Guidelines for Americans (150 minutes of moderate intensity aerobic activity and 2 days of 20 minutes of muscular strength activity), on insulin resistance in African American men.
This study will provide important information that can either strengthen or refine current physical activity recommendations.
Furthermore, this intervention will be delivered through community facilities in order to increase the likelihood that the intervention will be sustainable.
Study Type
Interventional
Enrollment (Actual)
113
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Pennington Biomedical Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- You completed the three run-in screening visits.
- You self-identify as a male of African descent.
- You are 35 to 70 years of age.
- You have a BMI (ratio of your height to your weight) greater than or equal to 25.0 kg/m2 and less than or equal to 40 kg/m2.
- You have a family history of diabetes.
- You are not currently physically active for 20 minutes each time for 3 or more days per week for the last 6 months. You are not participating in regular muscle building exercise.
- You are willing to give informed consent, willing to be randomized to either the healthy living intervention group or the aerobic plus resistance training exercise group, and willing to follow the protocol for the group to which you have been assigned.
Exclusion Criteria:
- You drink more than 14 alcoholic drinks per week.
- You plan to move out of the study area within the next 6 months, or plan to be out of the study area for more than 4 weeks during the course of the study.
- You have another member of your household participating in the study.
- You have serious health conditions that would interfere with the intervention goals
- History of cardiovascular disease (CVD) or disorders and are not under the care of a physician to treat the condition, or fail to provide written documentation from your physician indicating that the physician approves of your entering the study
- Have high blood pressure (greater than 155/99 mmHg) and are not under the care of a physician to treat the condition or fail to provide written documentation from your physician indicating that the physician approves of your entering the study
- Have a previous diagnosis of diabetes (Type 1 or 2) or a fasting plasma glucose of >125 mg/dl
- Have elevated bad cholesterol (greater than or equal to 190mg/dl) or triglycerides (great than or equal to 300) and are not under the care of a physician to treat the condition or fail to provide written documentation from your physician indicating that the physician approves of you entering the study
- Are currently taking medications for diabetes or chronic steroid use
- Have chronic or recurrent respiratory, gastrointestinal, neuromuscular, neurological or psychiatric conditions
- Have had cancer requiring treatment in the past 5 years, expect for non-melanoma skin cancers or cancers that have clearly been cured or in the option of the investigator carry an excellent prognosis (e.g., Stage 1 cervical cancer)
- Have autoimmune or collagen vascular diseases
- Have immunodeficiency diseases or HIV
- You have any other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator are life-threatening or that may interfere with study participation or the ability to follow the intervention protocol.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control Group
We will randomly assign 52 individuals to a no exercise healthy living group.
|
Participants randomized into the control group will not be provided with memberships to any exercise facility, nor will they receive behavioral instruction on how to increase physical activity.
They will receive information on living a healthy lifestyle.
Such minimal interventions have not been shown to increase physical activity in participants.
The participants in this group will undergo the baseline, 10 week, and 20 week testing.
Other Names:
|
|
Experimental: Aerobic Plus Resistance Training Group
We will randomly assign 52 individuals to an aerobic plus resistance training group.
|
Participants randomized to this intervention will engage in both aerobic and resistance training in accordance with Physical Activity Guidelines for Americans, that is 150 minutes of aerobic training and 2 days of additional 20 minutes of resistance training.
The aerobic training component will be completed on a treadmill and target training intensity will be self-selected at 65% to 85% of maximal aerobic capacity.
Each resistance training session will consist of both upper and lower body exercises: 2 sets of 9 exercises with each set consisting of 10 repetitions.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insulin Response to an Oral Glucose Tolerance Test Over 20 Weeks.
Time Frame: Baseline, week 10, week 20
|
An oral glucose tolerance test is a medical test in which glucose is given and blood samples are taken afterward to determine how quickly it is cleared from the blood.
The test is usually used to test for diabetes or insulin resistance.
|
Baseline, week 10, week 20
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diastolic Blood Pressure
Time Frame: 20 weeks
|
Blood pressure was measured at rest using a standard mercury sphygmomanometer.
|
20 weeks
|
|
Systolic Blood Pressure
Time Frame: 20 weeks
|
Blood pressure was measured at rest using a standard mercury sphygmomanometer.
|
20 weeks
|
|
Body Composition
Time Frame: 20 weeks
|
Body composition was assessed using the General Electric (General Electric; Milwaukee, WI) Lunar i-Dual energy X-ray absorptiometry.
|
20 weeks
|
|
Cardiorespiratory Fitness
Time Frame: 20 weeks
|
Fitness testing is being used as a measure of change in the aerobic component of the intervention.
Cardiorespiratory fitness maximal exercise tests were conducted using a standardized graded exercise testing protocol administered on a treadmill.
|
20 weeks
|
|
Muscular Strength
Time Frame: 20 weeks
|
Strength testing is performed in order to assess change in response to the resistance training program.
Muscular strength is measured via isokinetic testing on a Biodex System 4 Isokinetic Dynamometer.
|
20 weeks
|
|
Mood
Time Frame: 20 weeks
|
Depressive symptomatology is measured by the Center for Epidemiology Studies Depression Scale (CES-D).
The total score range is 0 to 60. Higher scores represent higher levels of depressive symptomatology.
|
20 weeks
|
|
Mental Health
Time Frame: 20 weeks
|
The Health Related Quality of Life (SF-36) questionnaire is being used to assess perceived quality of life, which usually improves through regular exercise.
The measure is scored on a T-scale, with a mean of 50 and standard deviation of 10.
Higher scores represent better functioning.
Scores below 40 suggest poorer functioning than normal, and scores above 60 represent better functioning than normal.
|
20 weeks
|
|
Physical Health
Time Frame: 20 weeks
|
The Health Related Quality of Life (SF-36) questionnaire is being used to assess perceived quality of life, which usually improves through regular exercise.
The measure is scored on a T-scale, with a mean of 50 and standard deviation of 10.
Higher scores represent better functioning.
Scores below 40 suggest poorer functioning than normal, and scores above 60 represent better functioning than normal.
|
20 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Robert L. Newton, PhD, Pennington Biomedical Research Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Newton RL Jr, Johnson WD, Hendrick C, Harris M, Andrews E 3rd, Johannsen N, Rodarte RQ, Hsia DS, Church TS. A randomized controlled exercise training trial on insulin sensitivity in African American men: The ARTIIS study: Major category: study design, statistical design, study protocols. Contemp Clin Trials. 2015 Jul;43:75-82. doi: 10.1016/j.cct.2015.05.004. Epub 2015 May 12.
- Newton RL Jr, Johnson WD, Larrivee S, Hendrick C, Harris M, Johannsen NM, Swift DL, Hsia DS, Church TS. A Randomized Community-based Exercise Training Trial in African American Men: Aerobic Plus Resistance Training and Insulin Sensitivity in African American Men. Med Sci Sports Exerc. 2020 Feb;52(2):408-416. doi: 10.1249/MSS.0000000000002149.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2012
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
March 31, 2018
Study Registration Dates
First Submitted
February 5, 2013
First Submitted That Met QC Criteria
February 6, 2013
First Posted (Estimated)
February 8, 2013
Study Record Updates
Last Update Posted (Actual)
October 31, 2024
Last Update Submitted That Met QC Criteria
October 29, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PBRC 11038
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin Resistance
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedEndoplasmic Reticulum Stress | HIV Related Insulin Resistance | Protease Inhibitor Related Insulin ResistanceUnited States
-
German Diabetes CenterYale UniversityRecruiting
-
National Institute of Diabetes and Digestive and...Active, not recruitingSevere Insulin ResistanceUnited States
-
Paloma Almeda-ValdésCompleted
-
Société des Produits Nestlé (SPN)CompletedInsulin Sensitivity/ResistanceSwitzerland
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
National Taiwan UniversityNational Cheng-Kung University HospitalCompletedExercise, Insulin Resistance, Visceral Adipose TissueTaiwan
-
University of CopenhagenNovo Nordisk A/S; Queen Mary University of London; University of SydneyNot yet recruitingInsulin Sensitivity/Resistance | Metabolic HealthDenmark
-
Assiut UniversityCompleted
-
University Health Network, TorontoCompletedInsulin Resistance Syndrome X | Pancreatic Beta Cell FunctionCanada
Clinical Trials on Control Group
-
Tasly Pharmaceutical Group Co., LtdCompleted
-
Chengdu Sport UniversityNot yet recruiting
-
Hanlim Pharm. Co., Ltd.Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
The First Affiliated Hospital of Zhejiang Chinese...Not yet recruitingAdolescent Idiopathic ScoliosisChina
-
International University of La RiojaCompletedPsychosis | Therapy | PsychologicalSpain
-
Physicians Committee for Responsible MedicineMetropolitan Police Department of Washington, D.C.SuspendedDiabetes Mellitus, Type 2 | Overweight | Blood PressureUnited States
-
The University of Hong Konghong Kong Cancer FundCompletedBreast Cancer | Yoga Therapy | Shoulder Joint Motion | Scar Contracture
-
Istanbul Arel UniversityCompletedMyofascial Pain | TMJ Disc DisorderTurkey